Table of Contents

company-logo

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

Glaukos Dividend Announcement

• Glaukos does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Glaukos dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Glaukos Dividend History

Glaukos Dividend Yield

Glaukos current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Glaukos stock? Use our calculator to estimate your expected dividend yield:

Glaukos Financial Ratios

P/E ratio-51.03
PEG ratio-1.15
P/B ratio11.42
ROE-26.64%
Payout ratio0.00%
Current ratio5.54
Quick ratio4.71
Cash Ratio1.40

Glaukos Dividend FAQ

Does Glaukos stock pay dividends?
Glaukos does not currently pay dividends to its shareholders.
Has Glaukos ever paid a dividend?
No, Glaukos has no a history of paying dividends to its shareholders. Glaukos is not known for its dividend payments.
Why doesn't Glaukos pay dividends?
There are several potential reasons why Glaukos would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Glaukos ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Glaukos has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Glaukos a dividend aristocrat?
Glaukos is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Glaukos a dividend king?
Glaukos is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Glaukos a dividend stock?
No, Glaukos is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Glaukos stocks?
To buy Glaukos you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Glaukos stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.